Paper42978552PubMed
Comparative outcomes of adjuvant treatment approaches in resected stage I-III gastric cancer.
Yildiz B and 3 others. Front Oncol, 2026.
Cite this record
ConductScience Library. Comparative outcomes of adjuvant treatment approaches in resected stage I-III gastric cancer. Papers, record 42978552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42978552
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparative outcomes of adjuvant treatment approaches in resected stage I-III gastric cancer.
- Journal
- Front Oncol
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-11-05
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29609047 | Lymphovascular invasion as a predictor for lymph node metastasis and a prognostic factor in gastric cancer patients under 70 years of age: A retrospective analysis. | Int J Surg | 2018 | https://conductscience.org/library/papers/29609047 | PubMed |
| 2 | 17440161 | Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial. | J Natl Cancer Inst | 2007 | https://conductscience.org/library/papers/17440161 | PubMed |
| 3 | 27697982 | Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2016 | https://conductscience.org/library/papers/27697982 | PubMed |
| 4 | 39023597 | Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel-Cisplatin-Fluorouracil (DCF) versus CRT plus Fluorouracil-Folinic Acid (FUFA) in Stage III Gastric Cancer. | J Cancer Res Ther | 2024 | https://conductscience.org/library/papers/39023597 | PubMed |
| 5 | 25223244 | Impact of extranodal extension on prognosis in lymph node-positive gastric cancer. | Br J Surg | 2014 | https://conductscience.org/library/papers/25223244 | PubMed |
| 6 | 29450755 | Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with Gastric Cancer After D2 Lymph Node Dissection: A Retrospective, Multi-Center Observational Study. | Ann Surg Oncol | 2018 | https://conductscience.org/library/papers/29450755 | PubMed |
| 7 | 25759484 | Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced gastric cancer patients who underwent curative gastrectomy and adjuvant chemotherapy. | Jpn J Clin Oncol | 2015 | https://conductscience.org/library/papers/25759484 | PubMed |
| 8 | 22184384 | Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. | J Clin Oncol | 2012 | https://conductscience.org/library/papers/22184384 | PubMed |
| 9 | 10450730 | Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. | Ann Surg | 1999 | https://conductscience.org/library/papers/10450730 | PubMed |
| 10 | 15082726 | Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. | J Clin Oncol | 2004 | https://conductscience.org/library/papers/15082726 | PubMed |
| 11 | 21414740 | Prospective, randomized trial comparing 5-FU/LV with or without oxaliplatin as adjuvant treatment following curative resection of gastric adenocarcinoma. | Eur J Surg Oncol | 2011 | https://conductscience.org/library/papers/21414740 | PubMed |
| 12 | 22226517 | Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. | Lancet | 2012 | https://conductscience.org/library/papers/22226517 | PubMed |
| 13 | 27664260 | Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Ann Oncol | 2016 | https://conductscience.org/library/papers/27664260 | PubMed |
| 14 | 27342689 | Japanese gastric cancer treatment guidelines 2014 (ver. 4). | Gastric Cancer | 2017 | https://conductscience.org/library/papers/27342689 | PubMed |
| 15 | 27412320 | Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis. | J Gastrointest Surg | 2016 | https://conductscience.org/library/papers/27412320 | PubMed |
| 16 | 25559811 | Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/25559811 | PubMed |
| 17 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 18 | 24707149 | Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/24707149 | PubMed |
| 19 | 21590318 | Clinicopathological analysis for recurrence of stage Ib gastric cancer (according to the second English edition of the Japanese classification of gastric carcinoma). | Gastric Cancer | 2011 | https://conductscience.org/library/papers/21590318 | PubMed |
| 20 | 17978289 | Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17978289 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42978552
GET https://conductscience.org/api/papers/v1/42978552/references?page=2